Axelyf

Seed
axelyf.com Biotech & Healthcare Brookline, United States
Total Funding $2.6M
Latest Round Undisclosed Seed
Last Announced Oct 13, 2026
Investors 3 Backers
Decision Makers 3 Verified

About Axelyf

Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Brookline, United States
Tracked Since Oct 15, 2026

Web & Domain Identity

Official Website axelyf.com
Domain Registered Date Nov 6, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

  2. Capital Raise

    Raised $2,600,000 · Seed

    startupintros.com

  3. Milestone

    Website domain registered

    axelyf.com

Investors & Backers

3
Brunnur Ventures
Omega ehf
Silfurberg

Funding History

2 Rounds
Seed equity · Oct 13, 2026
Undisclosed
Seed equity · Aug 29, 2025

Founders & Leadership

3

Daniel Frímannsson

Head of Nucleic Acid Technologies & Biology

Work email & phone locked Unlock →

John Lucas

Founder

Work email & phone locked Unlock →

Örn Almarsson

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts